Quick Links

Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This activity has been approved for AMA PRA Category 1 Credit™.

Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669.

Privacy Policy
Terms & Conditions
Executive Board
Faculty Portal
Google +
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2018
Physicians’ Education Resource ®, LLC.
All rights reserved.

13th Annual New York Lung Cancers Symposium

13th Annual New York Lung Cancers Symposium

13th Annual New York Lung Cancers Symposium®

Saturday, November 10, 2018
New York Marriott Marquis
1535 Broadway

New York, NY 10036
(888) 523-0366


The 13th Annual New York Lung Cancers Symposium is a 1-day educational and scientific meeting that will provide an update on state-of-the-art management of patients with lung cancer, as well as a focus on future therapies in development.

The past decade in lung cancer research has yielded a wealth of therapeutic options for patients with lung cancer, as well as greater knowledge of the many different subtypes of this disease. In particular, agents targeting oncogenic drivers and immunotherapeutic approaches have transformed the management of patients with lung cancer in recent years. Furthermore, numerous investigational approaches are in late-phase evaluation, with the potential to change standards of care in 2017, and beyond. However, although these developments hold the promise to further improve outcomes for patients with lung cancer, they also raise challenges for busy clinicians to maintain state-of-the-art approaches in their practices.

This year’s program, led by world-class thoracic oncologists, Mark G. Kris, MD, and Roman Perez-Soler, MD, will focus on a number of core areas that are key to optimizing care for patients with lung cancer, including targeted therapy, immunotherapy, adjuvant therapy, combined modality therapy, and approaches for challenging subtypes, such as squamous lung cancer. Participants will have an opportunity to learn from engaging presentations delivered by leading experts, as well as apply their knowledge in case-based panel discussions. This fast-paced, highly practical, and interactive forum will once again provide physicians who treat patients with lung cancer unique access to renowned international experts in the management of these tumors.

Target Audience

This educational activity is directed toward medical oncologists, radiation oncologists, thoracic surgeons, pulmonologists involved in the treatment and management of patients with lung cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of lung cancer may also participate.

Learning Objectives

Upon completion of this activity, participants should be better prepared to:

  • Apply testing strategies to optimize tumor characterization and inform clinical decision-making for the management of patients with lung cancers
  • Integrate prognostic and biomarker findings to inform personalized treatment planning and sequencing for patients with NSCLC and SCLC
  • Evaluate recent and emerging evidence concerning single agent and combination immunotherapeutic approaches to manage lung cancers
  • Explain current and emerging oncogene-driven NSCLC subtypes in the context of optimizing therapeutic sequencing for multiple lines of therapy
  • Determine optimized strategies for patients without mutations including the role of chemotherapies and antiangiogenic strategies in these settings
  • Assess proactive strategies to plan for and mitigate the impact of treatment-related toxicities in the care of patients with lung cancers

Program Chairs

Mark G. Kris, MD
Attending, Thoracic Oncology Service
William and Joy Ruane Chair in Thoracic Oncology
Memorial Sloan Kettering Cancer Center
New York, NY

Roman Perez-Soler, MD
Chairman, Department of Oncology
Montefiore Medical Center
Professor of Medicine and Molecular Pharmacology
Deputy Cancer Center Director
Albert Einstein College of Medicine
Bronx, NY

Become a Member

Forgot Password?
Calendar of Events
Filter By